Hillsdale Investment Management Inc. Moderna, Inc. Transaction History

Hillsdale Investment Management Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	SELL	$118.07 - $194.18 $247,947 - $407,778	-2,100 Reduced 98.13%	40 $5,000
Q2 2022 Aug 12, 2022	SELL	$117.13 - $176.59 $3,513 - $5,297	-30 Reduced 1.38%	2,140 $306,000
Q1 2022 Apr 28, 2022	BUY	$126.46 - $235.05 $12,646 - $23,505	100 Added 4.83%	2,170 $374,000
Q4 2021 Feb 07, 2022	SELL	$225.82 - $368.51 $74,972 - $122,345	-332 Reduced 13.82%	2,070 $525,000
Q3 2021 Oct 21, 2021	SELL	$221.9 - $484.47 $188,171 - $410,830	-848 Reduced 26.09%	2,402 $924,000
Q2 2021 Jul 29, 2021	BUY	$129.91 - $234.98 $422,207 - $763,685	3,250 New	3,250 $763,000

1,113

241M

9.26M

12.1M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Hillsdale Investment Management Inc., based on Form 13F filings with the SEC.

Stay updated on Hillsdale Investment Management Inc. with notifications on news.